01.04.2022 • News • Solvay

Solvay Settles Patent Dispute with China’s HySci

Solvay has reached full and final financial settlement with China’s HySci (Tianjin) Specialty Materials over a patent infringement suit for rare earth oxides.

The settlement relates to a judgement issued back in 2015 in favor of Solvay by the Tianjin 2nd Intermediate People’s Court and further confirmed by the Supreme People's Court. The ruling found that HySci had infringed the Belgian company’s Chinese patents and ordered it to cease producing and selling the products and pay material damages.

Rare earth oxides are used in automotive catalysts to abate noxious gases from engine exhausts. Solvay said that ever stricter air quality standards are requiring increasingly complex formulated rare earth oxides that have been developed after extensive research and innovation.

Author: Elaine Burridge, Freelance Journalist

Solvay

Company

Solvay

Rue du Prince Albert 33
1050 Bruxelles
Belgium

Company contact

I am interested in:

an offer
a callback
detailed information

Your request

salutation first name last name

country phone email

Please note our data protection information for the contact form.

Whitepaper

Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.